As of 2026-04-03, the Intrinsic Value of Nutex Health Inc (NUTX) is 112.16 USD. This NUTX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 98.44 USD, the upside of Nutex Health Inc is 13.90%.
The range of the Intrinsic Value is 58.12 - 2,184.78 USD
Based on its market price of 98.44 USD and our intrinsic valuation, Nutex Health Inc (NUTX) is undervalued by 13.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 58.12 - 2,184.78 | 112.16 | 13.9% |
| DCF (Growth 10y) | 60.53 - 2,559.55 | 121.99 | 23.9% |
| DCF (EBITDA 5y) | 103.74 - 995.58 | 267.58 | 171.8% |
| DCF (EBITDA 10y) | 64.00 - 1,257.04 | 158.86 | 61.4% |
| Fair Value | 46.06 - 46.06 | 46.06 | -53.21% |
| P/E | 111.46 - 764.39 | 418.60 | 325.2% |
| EV/EBITDA | 557.42 - 762.41 | 684.47 | 595.3% |
| EPV | (1.81) - 180.81 | 89.50 | -9.1% |
| DDM - Stable | 82.81 - 245.37 | 164.09 | 66.7% |
| DDM - Multi | 554.11 - 1,137.68 | 731.69 | 643.3% |
| Market Cap (mil) | 686.13 |
| Beta | 1.42 |
| Outstanding shares (mil) | 6.97 |
| Enterprise Value (mil) | 819.76 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.58% |
| Cost of Debt | 131.59% |
| WACC | 43.78% |